Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. (CMMB) Stock Competitors & Peer Comparison
See (CMMB) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CMMB | $3.44 | +285.96% | 903.1K | -1.74 | -$0.50 | N/A |
| VRTX | $385.19 | -2.51% | 99.7B | 27.63 | $14.07 | N/A |
| REGN | $584.98 | -0.76% | 59.6B | 14.43 | $39.67 | +0.46% |
| ALNY | $448.96 | -1.19% | 58.2B | -181.08 | -$2.45 | N/A |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| ARGX | $699.64 | +6.01% | 41.4B | 34.43 | $19.67 | N/A |
| BNTX | $104.59 | -5.67% | 25.3B | -63.30 | -$1.66 | N/A |
| BGNE | $184.71 | +0.49% | 20.2B | -22.55 | -$8.19 | N/A |
| SMMT | $26.55 | +1.34% | 19.5B | -26.01 | -$1.01 | N/A |
| DNA-WT | $0.27 | -2.76% | 18.7B | N/A | N/A | N/A |
Stock Comparison
CMMB vs VRTX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, VRTX has a market cap of 99.7B. Regarding current trading prices, CMMB is priced at $3.44, while VRTX trades at $385.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas VRTX's P/E ratio is 27.63. In terms of profitability, CMMB's ROE is -0.95%, compared to VRTX's ROE of +0.22%. Regarding short-term risk, CMMB is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check VRTX's competition here
CMMB vs REGN Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, REGN has a market cap of 59.6B. Regarding current trading prices, CMMB is priced at $3.44, while REGN trades at $584.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas REGN's P/E ratio is 14.43. In terms of profitability, CMMB's ROE is -0.95%, compared to REGN's ROE of +0.15%. Regarding short-term risk, CMMB is more volatile compared to REGN. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check REGN's competition here
CMMB vs ALNY Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ALNY has a market cap of 58.2B. Regarding current trading prices, CMMB is priced at $3.44, while ALNY trades at $448.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ALNY's P/E ratio is -181.08. In terms of profitability, CMMB's ROE is -0.95%, compared to ALNY's ROE of -2.74%. Regarding short-term risk, CMMB is more volatile compared to ALNY. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ALNY's competition here
CMMB vs SGEN Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, CMMB is priced at $3.44, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas SGEN's P/E ratio is -57.19. In terms of profitability, CMMB's ROE is -0.95%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, CMMB is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check SGEN's competition here
CMMB vs ARGX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ARGX has a market cap of 41.4B. Regarding current trading prices, CMMB is priced at $3.44, while ARGX trades at $699.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ARGX's P/E ratio is 34.43. In terms of profitability, CMMB's ROE is -0.95%, compared to ARGX's ROE of +0.26%. Regarding short-term risk, CMMB is more volatile compared to ARGX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ARGX's competition here
CMMB vs BNTX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, BNTX has a market cap of 25.3B. Regarding current trading prices, CMMB is priced at $3.44, while BNTX trades at $104.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas BNTX's P/E ratio is -63.30. In terms of profitability, CMMB's ROE is -0.95%, compared to BNTX's ROE of -0.02%. Regarding short-term risk, CMMB is more volatile compared to BNTX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check BNTX's competition here
CMMB vs BGNE Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, CMMB is priced at $3.44, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas BGNE's P/E ratio is -22.55. In terms of profitability, CMMB's ROE is -0.95%, compared to BGNE's ROE of -0.05%. Regarding short-term risk, CMMB is more volatile compared to BGNE. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check BGNE's competition here
CMMB vs SMMT Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, SMMT has a market cap of 19.5B. Regarding current trading prices, CMMB is priced at $3.44, while SMMT trades at $26.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas SMMT's P/E ratio is -26.01. In terms of profitability, CMMB's ROE is -0.95%, compared to SMMT's ROE of -2.09%. Regarding short-term risk, CMMB is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for CMMB.Check SMMT's competition here
CMMB vs DNA-WT Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, CMMB is priced at $3.44, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, CMMB's ROE is -0.95%, compared to DNA-WT's ROE of -0.45%. Regarding short-term risk, CMMB is more volatile compared to DNA-WT. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check DNA-WT's competition here
CMMB vs INCY Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, INCY has a market cap of 16.6B. Regarding current trading prices, CMMB is priced at $3.44, while INCY trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas INCY's P/E ratio is 20.04. In terms of profitability, CMMB's ROE is -0.95%, compared to INCY's ROE of +0.24%. Regarding short-term risk, CMMB is more volatile compared to INCY. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check INCY's competition here
CMMB vs RPRX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, RPRX has a market cap of 15.6B. Regarding current trading prices, CMMB is priced at $3.44, while RPRX trades at $35.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas RPRX's P/E ratio is 15.71. In terms of profitability, CMMB's ROE is -0.95%, compared to RPRX's ROE of +0.15%. Regarding short-term risk, CMMB is more volatile compared to RPRX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check RPRX's competition here
CMMB vs GMAB Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, GMAB has a market cap of 15.3B. Regarding current trading prices, CMMB is priced at $3.44, while GMAB trades at $24.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas GMAB's P/E ratio is 12.60. In terms of profitability, CMMB's ROE is -0.95%, compared to GMAB's ROE of +0.28%. Regarding short-term risk, CMMB is more volatile compared to GMAB. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check GMAB's competition here
CMMB vs UTHR Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, UTHR has a market cap of 13.8B. Regarding current trading prices, CMMB is priced at $3.44, while UTHR trades at $306.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas UTHR's P/E ratio is 11.91. In terms of profitability, CMMB's ROE is -0.95%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, CMMB is more volatile compared to UTHR. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check UTHR's competition here
CMMB vs KRTX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, CMMB is priced at $3.44, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas KRTX's P/E ratio is -28.09. In terms of profitability, CMMB's ROE is -0.95%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, CMMB is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check KRTX's competition here
CMMB vs ASND Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ASND has a market cap of 11.5B. Regarding current trading prices, CMMB is priced at $3.44, while ASND trades at $194.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ASND's P/E ratio is -36.05. In terms of profitability, CMMB's ROE is -0.95%, compared to ASND's ROE of +1.52%. Regarding short-term risk, CMMB is more volatile compared to ASND. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ASND's competition here
CMMB vs BMRN Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, BMRN has a market cap of 11.2B. Regarding current trading prices, CMMB is priced at $3.44, while BMRN trades at $57.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas BMRN's P/E ratio is 17.26. In terms of profitability, CMMB's ROE is -0.95%, compared to BMRN's ROE of +0.11%. Regarding short-term risk, CMMB is more volatile compared to BMRN. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check BMRN's competition here
CMMB vs EXEL Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, EXEL has a market cap of 10.2B. Regarding current trading prices, CMMB is priced at $3.44, while EXEL trades at $38.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas EXEL's P/E ratio is 18.22. In terms of profitability, CMMB's ROE is -0.95%, compared to EXEL's ROE of +0.28%. Regarding short-term risk, CMMB is more volatile compared to EXEL. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check EXEL's competition here
CMMB vs MRNA Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, MRNA has a market cap of 9.9B. Regarding current trading prices, CMMB is priced at $3.44, while MRNA trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas MRNA's P/E ratio is -3.38. In terms of profitability, CMMB's ROE is -0.95%, compared to MRNA's ROE of -0.27%. Regarding short-term risk, CMMB is more volatile compared to MRNA. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check MRNA's competition here
CMMB vs RXDX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, CMMB is priced at $3.44, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas RXDX's P/E ratio is -56.47. In terms of profitability, CMMB's ROE is -0.95%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, CMMB is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check RXDX's competition here
CMMB vs MDGL Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, MDGL has a market cap of 9.2B. Regarding current trading prices, CMMB is priced at $3.44, while MDGL trades at $424.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas MDGL's P/E ratio is -32.59. In terms of profitability, CMMB's ROE is -0.95%, compared to MDGL's ROE of -0.38%. Regarding short-term risk, CMMB is more volatile compared to MDGL. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check MDGL's competition here
CMMB vs BBIO Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, BBIO has a market cap of 9B. Regarding current trading prices, CMMB is priced at $3.44, while BBIO trades at $48.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas BBIO's P/E ratio is -11.45. In terms of profitability, CMMB's ROE is -0.95%, compared to BBIO's ROE of +0.51%. Regarding short-term risk, CMMB is more volatile compared to BBIO. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check BBIO's competition here
CMMB vs VRNA Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, VRNA has a market cap of 9B. Regarding current trading prices, CMMB is priced at $3.44, while VRNA trades at $105.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas VRNA's P/E ratio is -100.59. In terms of profitability, CMMB's ROE is -0.95%, compared to VRNA's ROE of -0.39%. Regarding short-term risk, CMMB is more volatile compared to VRNA. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check VRNA's competition here
CMMB vs TECH Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, TECH has a market cap of 8.9B. Regarding current trading prices, CMMB is priced at $3.44, while TECH trades at $56.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas TECH's P/E ratio is 123.28. In terms of profitability, CMMB's ROE is -0.95%, compared to TECH's ROE of +0.06%. Regarding short-term risk, CMMB is more volatile compared to TECH. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check TECH's competition here
CMMB vs IMGN Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, CMMB is priced at $3.44, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas IMGN's P/E ratio is -111.55. In terms of profitability, CMMB's ROE is -0.95%, compared to IMGN's ROE of -1.43%. Regarding short-term risk, CMMB is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check IMGN's competition here
CMMB vs HALO Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, HALO has a market cap of 8.4B. Regarding current trading prices, CMMB is priced at $3.44, while HALO trades at $72.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas HALO's P/E ratio is 16.52. In terms of profitability, CMMB's ROE is -0.95%, compared to HALO's ROE of +1.37%. Regarding short-term risk, CMMB is more volatile compared to HALO. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check HALO's competition here
CMMB vs BPMC Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, BPMC has a market cap of 8.4B. Regarding current trading prices, CMMB is priced at $3.44, while BPMC trades at $129.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas BPMC's P/E ratio is -51.58. In terms of profitability, CMMB's ROE is -0.95%, compared to BPMC's ROE of -0.49%. Regarding short-term risk, CMMB is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check BPMC's competition here
CMMB vs CERE Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, CMMB is priced at $3.44, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas CERE's P/E ratio is -16.47. In terms of profitability, CMMB's ROE is -0.95%, compared to CERE's ROE of -0.72%. Regarding short-term risk, CMMB is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check CERE's competition here
CMMB vs ROIV Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ROIV has a market cap of 7.9B. Regarding current trading prices, CMMB is priced at $3.44, while ROIV trades at $11.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ROIV's P/E ratio is -10.68. In terms of profitability, CMMB's ROE is -0.95%, compared to ROIV's ROE of -0.10%. Regarding short-term risk, CMMB is more volatile compared to ROIV. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ROIV's competition here
CMMB vs ROIVW Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ROIVW has a market cap of 7.8B. Regarding current trading prices, CMMB is priced at $3.44, while ROIVW trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ROIVW's P/E ratio is -0.67. In terms of profitability, CMMB's ROE is -0.95%, compared to ROIVW's ROE of -0.10%. Regarding short-term risk, CMMB is more volatile compared to ROIVW. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ROIVW's competition here
CMMB vs JAZZ Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, JAZZ has a market cap of 7.6B. Regarding current trading prices, CMMB is priced at $3.44, while JAZZ trades at $124.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas JAZZ's P/E ratio is -17.85. In terms of profitability, CMMB's ROE is -0.95%, compared to JAZZ's ROE of -0.10%. Regarding short-term risk, CMMB is more volatile compared to JAZZ. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check JAZZ's competition here
CMMB vs CORT Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, CORT has a market cap of 7.3B. Regarding current trading prices, CMMB is priced at $3.44, while CORT trades at $68.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas CORT's P/E ratio is 61.45. In terms of profitability, CMMB's ROE is -0.95%, compared to CORT's ROE of +0.20%. Regarding short-term risk, CMMB is more volatile compared to CORT. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check CORT's competition here
CMMB vs RVMD Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, RVMD has a market cap of 6.7B. Regarding current trading prices, CMMB is priced at $3.44, while RVMD trades at $36.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas RVMD's P/E ratio is -7.89. In terms of profitability, CMMB's ROE is -0.95%, compared to RVMD's ROE of -0.42%. Regarding short-term risk, CMMB is more volatile compared to RVMD. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check RVMD's competition here
CMMB vs IONS Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, IONS has a market cap of 6.7B. Regarding current trading prices, CMMB is priced at $3.44, while IONS trades at $42.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas IONS's P/E ratio is -23.76. In terms of profitability, CMMB's ROE is -0.95%, compared to IONS's ROE of -0.45%. Regarding short-term risk, CMMB is more volatile compared to IONS. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check IONS's competition here
CMMB vs RYTM Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, RYTM has a market cap of 6.6B. Regarding current trading prices, CMMB is priced at $3.44, while RYTM trades at $100.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas RYTM's P/E ratio is -32.96. In terms of profitability, CMMB's ROE is -0.95%, compared to RYTM's ROE of -1.55%. Regarding short-term risk, CMMB is more volatile compared to RYTM. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check RYTM's competition here
CMMB vs RETA Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, CMMB is priced at $3.44, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas RETA's P/E ratio is -66.29. In terms of profitability, CMMB's ROE is -0.95%, compared to RETA's ROE of +0.47%. Regarding short-term risk, CMMB is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check RETA's competition here
CMMB vs ABVX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ABVX has a market cap of 5.9B. Regarding current trading prices, CMMB is priced at $3.44, while ABVX trades at $79.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ABVX's P/E ratio is -22.52. In terms of profitability, CMMB's ROE is -0.95%, compared to ABVX's ROE of -1.62%. Regarding short-term risk, CMMB is more volatile compared to ABVX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ABVX's competition here
CMMB vs RNA Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, RNA has a market cap of 5.8B. Regarding current trading prices, CMMB is priced at $3.44, while RNA trades at $45.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas RNA's P/E ratio is -12.72. In terms of profitability, CMMB's ROE is -0.95%, compared to RNA's ROE of -0.33%. Regarding short-term risk, CMMB is more volatile compared to RNA. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check RNA's competition here
CMMB vs AXSM Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, AXSM has a market cap of 5.8B. Regarding current trading prices, CMMB is priced at $3.44, while AXSM trades at $118.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas AXSM's P/E ratio is -22.99. In terms of profitability, CMMB's ROE is -0.95%, compared to AXSM's ROE of -3.58%. Regarding short-term risk, CMMB is more volatile compared to AXSM. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check AXSM's competition here
CMMB vs ABCM Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, CMMB is priced at $3.44, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, CMMB's ROE is -0.95%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, CMMB is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ABCM's competition here
CMMB vs ISEE Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, CMMB is priced at $3.44, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ISEE's P/E ratio is -22.44. In terms of profitability, CMMB's ROE is -0.95%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, CMMB is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ISEE's competition here
CMMB vs NUVL Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, NUVL has a market cap of 5.3B. Regarding current trading prices, CMMB is priced at $3.44, while NUVL trades at $74.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas NUVL's P/E ratio is -15.05. In terms of profitability, CMMB's ROE is -0.95%, compared to NUVL's ROE of -0.33%. Regarding short-term risk, CMMB is more volatile compared to NUVL. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check NUVL's competition here
CMMB vs MRUS Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, MRUS has a market cap of 5B. Regarding current trading prices, CMMB is priced at $3.44, while MRUS trades at $65.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas MRUS's P/E ratio is -11.78. In terms of profitability, CMMB's ROE is -0.95%, compared to MRUS's ROE of -0.55%. Regarding short-term risk, CMMB is more volatile compared to MRUS. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check MRUS's competition here
CMMB vs CRSP Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, CRSP has a market cap of 4.9B. Regarding current trading prices, CMMB is priced at $3.44, while CRSP trades at $54.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas CRSP's P/E ratio is -10.02. In terms of profitability, CMMB's ROE is -0.95%, compared to CRSP's ROE of -0.25%. Regarding short-term risk, CMMB is more volatile compared to CRSP. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check CRSP's competition here
CMMB vs ALKS Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ALKS has a market cap of 4.8B. Regarding current trading prices, CMMB is priced at $3.44, while ALKS trades at $28.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ALKS's P/E ratio is 14.01. In terms of profitability, CMMB's ROE is -0.95%, compared to ALKS's ROE of +0.24%. Regarding short-term risk, CMMB is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ALKS's competition here
CMMB vs TGTX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, TGTX has a market cap of 4.5B. Regarding current trading prices, CMMB is priced at $3.44, while TGTX trades at $28.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas TGTX's P/E ratio is 75.08. In terms of profitability, CMMB's ROE is -0.95%, compared to TGTX's ROE of +0.29%. Regarding short-term risk, CMMB is more volatile compared to TGTX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check TGTX's competition here
CMMB vs ALPN Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, CMMB is priced at $3.44, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ALPN's P/E ratio is -101.52. In terms of profitability, CMMB's ROE is -0.95%, compared to ALPN's ROE of -0.13%. Regarding short-term risk, CMMB is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ALPN's competition here
CMMB vs CYTK Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, CYTK has a market cap of 4.4B. Regarding current trading prices, CMMB is priced at $3.44, while CYTK trades at $38.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas CYTK's P/E ratio is -7.23. In terms of profitability, CMMB's ROE is -0.95%, compared to CYTK's ROE of +3.09%. Regarding short-term risk, CMMB is more volatile compared to CYTK. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check CYTK's competition here
CMMB vs ACAD Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ACAD has a market cap of 4.3B. Regarding current trading prices, CMMB is priced at $3.44, while ACAD trades at $25.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ACAD's P/E ratio is 19.04. In terms of profitability, CMMB's ROE is -0.95%, compared to ACAD's ROE of +0.31%. Regarding short-term risk, CMMB is more volatile compared to ACAD. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ACAD's competition here
CMMB vs KRYS Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, KRYS has a market cap of 4.2B. Regarding current trading prices, CMMB is priced at $3.44, while KRYS trades at $144.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas KRYS's P/E ratio is 29.83. In terms of profitability, CMMB's ROE is -0.95%, compared to KRYS's ROE of +0.15%. Regarding short-term risk, CMMB is more volatile compared to KRYS. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check KRYS's competition here
CMMB vs OPT Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, CMMB is priced at $3.44, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas OPT's P/E ratio is -1.52. In terms of profitability, CMMB's ROE is -0.95%, compared to OPT's ROE of +2.60%. Regarding short-term risk, CMMB is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check OPT's competition here
CMMB vs TLX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, TLX has a market cap of 4.1B. Regarding current trading prices, CMMB is priced at $3.44, while TLX trades at $12.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas TLX's P/E ratio is 610.00. In terms of profitability, CMMB's ROE is -0.95%, compared to TLX's ROE of +0.10%. Regarding short-term risk, CMMB is more volatile compared to TLX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check TLX's competition here
CMMB vs MRTX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, CMMB is priced at $3.44, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas MRTX's P/E ratio is -4.82. In terms of profitability, CMMB's ROE is -0.95%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, CMMB is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check MRTX's competition here
CMMB vs ADMA Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ADMA has a market cap of 4.1B. Regarding current trading prices, CMMB is priced at $3.44, while ADMA trades at $17.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ADMA's P/E ratio is 20.01. In terms of profitability, CMMB's ROE is -0.95%, compared to ADMA's ROE of +0.62%. Regarding short-term risk, CMMB is more volatile compared to ADMA. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ADMA's competition here
CMMB vs AAPG Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, AAPG has a market cap of 4B. Regarding current trading prices, CMMB is priced at $3.44, while AAPG trades at $42.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas AAPG's P/E ratio is -21.44. In terms of profitability, CMMB's ROE is -0.95%, compared to AAPG's ROE of -0.79%. Regarding short-term risk, CMMB is more volatile compared to AAPG. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check AAPG's competition here
CMMB vs PCVX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, PCVX has a market cap of 4B. Regarding current trading prices, CMMB is priced at $3.44, while PCVX trades at $30.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas PCVX's P/E ratio is -7.41. In terms of profitability, CMMB's ROE is -0.95%, compared to PCVX's ROE of -0.17%. Regarding short-term risk, CMMB is more volatile compared to PCVX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check PCVX's competition here
CMMB vs PTCT Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, PTCT has a market cap of 3.9B. Regarding current trading prices, CMMB is priced at $3.44, while PTCT trades at $48.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas PTCT's P/E ratio is 6.99. In terms of profitability, CMMB's ROE is -0.95%, compared to PTCT's ROE of -0.99%. Regarding short-term risk, CMMB is more volatile compared to PTCT. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check PTCT's competition here
CMMB vs ACLX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ACLX has a market cap of 3.8B. Regarding current trading prices, CMMB is priced at $3.44, while ACLX trades at $69.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ACLX's P/E ratio is -20.09. In terms of profitability, CMMB's ROE is -0.95%, compared to ACLX's ROE of -0.43%. Regarding short-term risk, CMMB is more volatile compared to ACLX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ACLX's competition here
CMMB vs AKRO Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, AKRO has a market cap of 3.8B. Regarding current trading prices, CMMB is priced at $3.44, while AKRO trades at $47.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas AKRO's P/E ratio is -12.34. In terms of profitability, CMMB's ROE is -0.95%, compared to AKRO's ROE of -0.32%. Regarding short-term risk, CMMB is more volatile compared to AKRO. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check AKRO's competition here
CMMB vs RYZB Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, CMMB is priced at $3.44, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas RYZB's P/E ratio is -57.86. In terms of profitability, CMMB's ROE is -0.95%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, CMMB is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check RYZB's competition here
CMMB vs ZLAB Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ZLAB has a market cap of 3.7B. Regarding current trading prices, CMMB is priced at $3.44, while ZLAB trades at $34.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ZLAB's P/E ratio is -17.01. In terms of profitability, CMMB's ROE is -0.95%, compared to ZLAB's ROE of -0.27%. Regarding short-term risk, CMMB is more volatile compared to ZLAB. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ZLAB's competition here
CMMB vs CBAY Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, CMMB is priced at $3.44, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas CBAY's P/E ratio is -32.81. In terms of profitability, CMMB's ROE is -0.95%, compared to CBAY's ROE of -0.64%. Regarding short-term risk, CMMB is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check CBAY's competition here
CMMB vs MIRM Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, MIRM has a market cap of 3.6B. Regarding current trading prices, CMMB is priced at $3.44, while MIRM trades at $72.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas MIRM's P/E ratio is -59.35. In terms of profitability, CMMB's ROE is -0.95%, compared to MIRM's ROE of -0.25%. Regarding short-term risk, CMMB is more volatile compared to MIRM. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check MIRM's competition here
CMMB vs SWTX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, CMMB is priced at $3.44, while SWTX trades at $46.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas SWTX's P/E ratio is -13.78. In terms of profitability, CMMB's ROE is -0.95%, compared to SWTX's ROE of -0.51%. Regarding short-term risk, CMMB is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check SWTX's competition here
CMMB vs PTGX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, PTGX has a market cap of 3.5B. Regarding current trading prices, CMMB is priced at $3.44, while PTGX trades at $56.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas PTGX's P/E ratio is 77.92. In terms of profitability, CMMB's ROE is -0.95%, compared to PTGX's ROE of +0.08%. Regarding short-term risk, CMMB is more volatile compared to PTGX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check PTGX's competition here
CMMB vs SLNO Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, SLNO has a market cap of 3.5B. Regarding current trading prices, CMMB is priced at $3.44, while SLNO trades at $68.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas SLNO's P/E ratio is -15.75. In terms of profitability, CMMB's ROE is -0.95%, compared to SLNO's ROE of -0.74%. Regarding short-term risk, CMMB is more volatile compared to SLNO. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check SLNO's competition here
CMMB vs APLS Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, APLS has a market cap of 3.5B. Regarding current trading prices, CMMB is priced at $3.44, while APLS trades at $27.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas APLS's P/E ratio is -15.04. In terms of profitability, CMMB's ROE is -0.95%, compared to APLS's ROE of -1.16%. Regarding short-term risk, CMMB is more volatile compared to APLS. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check APLS's competition here
CMMB vs MLTX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, MLTX has a market cap of 3.5B. Regarding current trading prices, CMMB is priced at $3.44, while MLTX trades at $53.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas MLTX's P/E ratio is -19.58. In terms of profitability, CMMB's ROE is -0.95%, compared to MLTX's ROE of -0.42%. Regarding short-term risk, CMMB is more volatile compared to MLTX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check MLTX's competition here
CMMB vs MTSR Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, MTSR has a market cap of 3.4B. Regarding current trading prices, CMMB is priced at $3.44, while MTSR trades at $32.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas MTSR's P/E ratio is -11.12. In terms of profitability, CMMB's ROE is -0.95%, compared to MTSR's ROE of -0.90%. Regarding short-term risk, CMMB is more volatile compared to MTSR. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check MTSR's competition here
CMMB vs SRRK Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, SRRK has a market cap of 3.2B. Regarding current trading prices, CMMB is priced at $3.44, while SRRK trades at $34.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas SRRK's P/E ratio is -11.41. In terms of profitability, CMMB's ROE is -0.95%, compared to SRRK's ROE of -1.27%. Regarding short-term risk, CMMB is more volatile compared to SRRK. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check SRRK's competition here
CMMB vs LEGN Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, LEGN has a market cap of 3.2B. Regarding current trading prices, CMMB is priced at $3.44, while LEGN trades at $35.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas LEGN's P/E ratio is -19.44. In terms of profitability, CMMB's ROE is -0.95%, compared to LEGN's ROE of -0.31%. Regarding short-term risk, CMMB is more volatile compared to LEGN. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check LEGN's competition here
CMMB vs LGND Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, LGND has a market cap of 3.1B. Regarding current trading prices, CMMB is priced at $3.44, while LGND trades at $160.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas LGND's P/E ratio is -39.30. In terms of profitability, CMMB's ROE is -0.95%, compared to LGND's ROE of -0.09%. Regarding short-term risk, CMMB is more volatile compared to LGND. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check LGND's competition here
CMMB vs KYMR Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, KYMR has a market cap of 3B. Regarding current trading prices, CMMB is priced at $3.44, while KYMR trades at $43.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas KYMR's P/E ratio is -11.98. In terms of profitability, CMMB's ROE is -0.95%, compared to KYMR's ROE of -0.32%. Regarding short-term risk, CMMB is more volatile compared to KYMR. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check KYMR's competition here
CMMB vs XENE Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, XENE has a market cap of 2.9B. Regarding current trading prices, CMMB is priced at $3.44, while XENE trades at $38.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas XENE's P/E ratio is -10.74. In terms of profitability, CMMB's ROE is -0.95%, compared to XENE's ROE of -0.39%. Regarding short-term risk, CMMB is more volatile compared to XENE. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check XENE's competition here
CMMB vs VKTX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, VKTX has a market cap of 2.9B. Regarding current trading prices, CMMB is priced at $3.44, while VKTX trades at $25.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas VKTX's P/E ratio is -16.79. In terms of profitability, CMMB's ROE is -0.95%, compared to VKTX's ROE of -0.20%. Regarding short-term risk, CMMB is more volatile compared to VKTX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check VKTX's competition here
CMMB vs ARWR Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, ARWR has a market cap of 2.9B. Regarding current trading prices, CMMB is priced at $3.44, while ARWR trades at $21.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas ARWR's P/E ratio is -17.26. In terms of profitability, CMMB's ROE is -0.95%, compared to ARWR's ROE of -0.41%. Regarding short-term risk, CMMB is more volatile compared to ARWR. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check ARWR's competition here
CMMB vs MORF Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, MORF has a market cap of 2.9B. Regarding current trading prices, CMMB is priced at $3.44, while MORF trades at $56.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas MORF's P/E ratio is -14.88. In terms of profitability, CMMB's ROE is -0.95%, compared to MORF's ROE of -0.16%. Regarding short-term risk, CMMB is more volatile compared to MORF. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check MORF's competition here
CMMB vs MOR Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, MOR has a market cap of 2.9B. Regarding current trading prices, CMMB is priced at $3.44, while MOR trades at $18.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas MOR's P/E ratio is -12.64. In terms of profitability, CMMB's ROE is -0.95%, compared to MOR's ROE of -1.84%. Regarding short-term risk, CMMB is more volatile compared to MOR. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check MOR's competition here
CMMB vs CRNX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, CRNX has a market cap of 2.8B. Regarding current trading prices, CMMB is priced at $3.44, while CRNX trades at $30.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas CRNX's P/E ratio is -7.34. In terms of profitability, CMMB's ROE is -0.95%, compared to CRNX's ROE of -0.32%. Regarding short-term risk, CMMB is more volatile compared to CRNX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check CRNX's competition here
CMMB vs RARE Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, RARE has a market cap of 2.8B. Regarding current trading prices, CMMB is priced at $3.44, while RARE trades at $29.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas RARE's P/E ratio is -5.34. In terms of profitability, CMMB's ROE is -0.95%, compared to RARE's ROE of -2.37%. Regarding short-term risk, CMMB is more volatile compared to RARE. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check RARE's competition here
CMMB vs NAMS Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, NAMS has a market cap of 2.8B. Regarding current trading prices, CMMB is priced at $3.44, while NAMS trades at $25.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas NAMS's P/E ratio is -15.53. In terms of profitability, CMMB's ROE is -0.95%, compared to NAMS's ROE of -0.25%. Regarding short-term risk, CMMB is more volatile compared to NAMS. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check NAMS's competition here
CMMB vs KDNY Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, KDNY has a market cap of 2.7B. Regarding current trading prices, CMMB is priced at $3.44, while KDNY trades at $40.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas KDNY's P/E ratio is -12.47. In terms of profitability, CMMB's ROE is -0.95%, compared to KDNY's ROE of -0.41%. Regarding short-term risk, CMMB is more volatile compared to KDNY. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check KDNY's competition here
CMMB vs MYOV Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, MYOV has a market cap of 2.6B. Regarding current trading prices, CMMB is priced at $3.44, while MYOV trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas MYOV's P/E ratio is -14.05. In terms of profitability, CMMB's ROE is -0.95%, compared to MYOV's ROE of +0.50%. Regarding short-term risk, CMMB is more volatile compared to MYOV. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check MYOV's competition here
CMMB vs IMVT Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, IMVT has a market cap of 2.6B. Regarding current trading prices, CMMB is priced at $3.44, while IMVT trades at $14.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas IMVT's P/E ratio is -5.24. In terms of profitability, CMMB's ROE is -0.95%, compared to IMVT's ROE of -0.84%. Regarding short-term risk, CMMB is more volatile compared to IMVT. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check IMVT's competition here
CMMB vs CPRX Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, CPRX has a market cap of 2.5B. Regarding current trading prices, CMMB is priced at $3.44, while CPRX trades at $19.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas CPRX's P/E ratio is 12.50. In terms of profitability, CMMB's ROE is -0.95%, compared to CPRX's ROE of +0.27%. Regarding short-term risk, CMMB is more volatile compared to CPRX. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check CPRX's competition here
CMMB vs KNSA Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, KNSA has a market cap of 2.4B. Regarding current trading prices, CMMB is priced at $3.44, while KNSA trades at $33.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas KNSA's P/E ratio is 660.80. In terms of profitability, CMMB's ROE is -0.95%, compared to KNSA's ROE of +0.01%. Regarding short-term risk, CMMB is more volatile compared to KNSA. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check KNSA's competition here
CMMB vs TARS Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, TARS has a market cap of 2.4B. Regarding current trading prices, CMMB is priced at $3.44, while TARS trades at $57.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas TARS's P/E ratio is -24.72. In terms of profitability, CMMB's ROE is -0.95%, compared to TARS's ROE of -0.32%. Regarding short-term risk, CMMB is more volatile compared to TARS. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check TARS's competition here
CMMB vs PRVB Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, PRVB has a market cap of 2.4B. Regarding current trading prices, CMMB is priced at $3.44, while PRVB trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas PRVB's P/E ratio is -16.43. In terms of profitability, CMMB's ROE is -0.95%, compared to PRVB's ROE of +1.33%. Regarding short-term risk, CMMB is more volatile compared to PRVB. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check PRVB's competition here
CMMB vs LBPH Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, LBPH has a market cap of 2.3B. Regarding current trading prices, CMMB is priced at $3.44, while LBPH trades at $59.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas LBPH's P/E ratio is -26.66. In terms of profitability, CMMB's ROE is -0.95%, compared to LBPH's ROE of -0.21%. Regarding short-term risk, CMMB is more volatile compared to LBPH. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check LBPH's competition here
CMMB vs VCYT Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, VCYT has a market cap of 2.3B. Regarding current trading prices, CMMB is priced at $3.44, while VCYT trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas VCYT's P/E ratio is 86.91. In terms of profitability, CMMB's ROE is -0.95%, compared to VCYT's ROE of +0.02%. Regarding short-term risk, CMMB is more volatile compared to VCYT. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check VCYT's competition here
CMMB vs FOLD Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, FOLD has a market cap of 2.3B. Regarding current trading prices, CMMB is priced at $3.44, while FOLD trades at $7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas FOLD's P/E ratio is -62.33. In terms of profitability, CMMB's ROE is -0.95%, compared to FOLD's ROE of -0.20%. Regarding short-term risk, CMMB is more volatile compared to FOLD. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check FOLD's competition here
CMMB vs CNTA Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, CNTA has a market cap of 2.3B. Regarding current trading prices, CMMB is priced at $3.44, while CNTA trades at $16.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas CNTA's P/E ratio is -9.19. In terms of profitability, CMMB's ROE is -0.95%, compared to CNTA's ROE of -0.56%. Regarding short-term risk, CMMB is more volatile compared to CNTA. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check CNTA's competition here
CMMB vs DNLI Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, DNLI has a market cap of 2.3B. Regarding current trading prices, CMMB is priced at $3.44, while DNLI trades at $15.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas DNLI's P/E ratio is -5.54. In terms of profitability, CMMB's ROE is -0.95%, compared to DNLI's ROE of -0.41%. Regarding short-term risk, CMMB is more volatile compared to DNLI. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check DNLI's competition here
CMMB vs DICE Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, DICE has a market cap of 2.3B. Regarding current trading prices, CMMB is priced at $3.44, while DICE trades at $47.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas DICE's P/E ratio is -21.91. In terms of profitability, CMMB's ROE is -0.95%, compared to DICE's ROE of +0.56%. Regarding short-term risk, CMMB is more volatile compared to DICE. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check DICE's competition here
CMMB vs LQDA Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, LQDA has a market cap of 2.3B. Regarding current trading prices, CMMB is priced at $3.44, while LQDA trades at $27.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas LQDA's P/E ratio is -14.42. In terms of profitability, CMMB's ROE is -0.95%, compared to LQDA's ROE of -1.58%. Regarding short-term risk, CMMB is more volatile compared to LQDA. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check LQDA's competition here
CMMB vs APGE Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, APGE has a market cap of 2.2B. Regarding current trading prices, CMMB is priced at $3.44, while APGE trades at $37.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas APGE's P/E ratio is -8.92. In terms of profitability, CMMB's ROE is -0.95%, compared to APGE's ROE of -0.23%. Regarding short-term risk, CMMB is more volatile compared to APGE. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check APGE's competition here
CMMB vs IDYA Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, IDYA has a market cap of 2.2B. Regarding current trading prices, CMMB is priced at $3.44, while IDYA trades at $24.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas IDYA's P/E ratio is -6.43. In terms of profitability, CMMB's ROE is -0.95%, compared to IDYA's ROE of -0.31%. Regarding short-term risk, CMMB is more volatile compared to IDYA. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check IDYA's competition here
CMMB vs AGIO Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, AGIO has a market cap of 2.2B. Regarding current trading prices, CMMB is priced at $3.44, while AGIO trades at $37.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas AGIO's P/E ratio is 3.30. In terms of profitability, CMMB's ROE is -0.95%, compared to AGIO's ROE of +0.43%. Regarding short-term risk, CMMB is more volatile compared to AGIO. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check AGIO's competition here
CMMB vs HRMY Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, HRMY has a market cap of 2.2B. Regarding current trading prices, CMMB is priced at $3.44, while HRMY trades at $37.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas HRMY's P/E ratio is 12.07. In terms of profitability, CMMB's ROE is -0.95%, compared to HRMY's ROE of +0.26%. Regarding short-term risk, CMMB is more volatile compared to HRMY. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check HRMY's competition here
CMMB vs CALT Comparison August 2025
CMMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMMB stands at 903.1K. In comparison, CALT has a market cap of 2.1B. Regarding current trading prices, CMMB is priced at $3.44, while CALT trades at $40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMMB currently has a P/E ratio of -1.74, whereas CALT's P/E ratio is -22.73. In terms of profitability, CMMB's ROE is -0.95%, compared to CALT's ROE of -1.67%. Regarding short-term risk, CMMB is more volatile compared to CALT. This indicates potentially higher risk in terms of short-term price fluctuations for CMMB.Check CALT's competition here